These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3128052)

  • 1. Free amino acid pattern of cerebrospinal fluid in amyotrophic lateral sclerosis.
    Meier DH; Schott KJ
    Acta Neurol Scand; 1988 Jan; 77(1):50-3. PubMed ID: 3128052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Free amino acid levels in amyotrophic lateral sclerosis.
    Patten BM; Harati Y; Acosta L; Jung SS; Felmus MT
    Ann Neurol; 1978 Apr; 3(4):305-9. PubMed ID: 666270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amyotrophic lateral sclerosis: amino acid levels in plasma and cerebrospinal fluid.
    Perry TL; Krieger C; Hansen S; Eisen A
    Ann Neurol; 1990 Jul; 28(1):12-7. PubMed ID: 2375629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in CSF amino acid concentrations during the evolution of amyotrophic lateral sclerosis.
    Blin O; Samuel D; Nieoullon A; Serratice G
    J Neurol Neurosurg Psychiatry; 1994 Jan; 57(1):119-20. PubMed ID: 8301293
    [No Abstract]   [Full Text] [Related]  

  • 5. Cerebrospinal fluid amino acids in amyotrophic lateral sclerosis.
    Kornhuber ME; Kornhuber J
    Ann Neurol; 1992 Apr; 31(4):449-50. PubMed ID: 1586146
    [No Abstract]   [Full Text] [Related]  

  • 6. Cerebrospinal fluid (CSF) findings in amyotrophic lateral sclerosis.
    Leonardi A; Abbruzzese G; Arata L; Cocito L; Vische M
    J Neurol; 1984; 231(2):75-8. PubMed ID: 6737012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Some CSF Kynurenine Pathway Intermediates Associated with Disease Evolution in Amyotrophic Lateral Sclerosis.
    Alarcan H; Chaumond R; Emond P; Benz-De Bretagne I; Lefèvre A; Bakkouche SE; Veyrat-Durebex C; Vourc'h P; Andres C; Corcia P; Blasco H
    Biomolecules; 2021 May; 11(5):. PubMed ID: 34063031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fasting plasma and CSF amino acid levels in amyotrophic lateral sclerosis: a subtype analysis.
    Camu W; Billiard M; Baldy-Moulinier M
    Acta Neurol Scand; 1993 Jul; 88(1):51-5. PubMed ID: 8372631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Familial amyotrophic lateral sclerosis associated with Huntington chorea with increased aspartate level in the cerebrospinal fluid].
    Blin O; Samuel D; Guieu R; Pouget J; Nieoullon A; Serratrice G
    Rev Neurol (Paris); 1992; 148(2):144-6. PubMed ID: 1534926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma and CSF amino acid levels in ALS.
    Loeb C; Mainardi P; Besio G; Lunardi G; Cogliolo I; Pioli F
    Acta Neurol Scand; 1994 Sep; 90(3):223-4. PubMed ID: 7847066
    [No Abstract]   [Full Text] [Related]  

  • 11. Etiogenic factors present in the cerebrospinal fluid from amyotrophic lateral sclerosis patients induce predominantly pro-inflammatory responses in microglia.
    Mishra PS; Vijayalakshmi K; Nalini A; Sathyaprabha TN; Kramer BW; Alladi PA; Raju TR
    J Neuroinflammation; 2017 Dec; 14(1):251. PubMed ID: 29246232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated levels of ferritin in the cerebrospinal fluid of amyotrophic lateral sclerosis patients.
    Zheng Y; Gao L; Wang D; Zang D
    Acta Neurol Scand; 2017 Aug; 136(2):145-150. PubMed ID: 27804118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased cerebrospinal fluid cGMP levels in patients with amyotrophic lateral sclerosis.
    Iłecka J
    J Neural Transm (Vienna); 2004 Feb; 111(2):167-72. PubMed ID: 14767719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal fluid angiogenin level in patients with amyotrophic lateral sclerosis.
    Iłzecka J
    Acta Clin Croat; 2008 Jun; 47(2):77-9. PubMed ID: 18949901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of elevated phosphorylated neurofilament heavy chains in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
    De Schaepdryver M; Jeromin A; Gille B; Claeys KG; Herbst V; Brix B; Van Damme P; Poesen K
    J Neurol Neurosurg Psychiatry; 2018 Apr; 89(4):367-373. PubMed ID: 29054919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Label-Free LC-MS/MS Proteomic Analysis of Cerebrospinal Fluid Identifies Protein/Pathway Alterations and Candidate Biomarkers for Amyotrophic Lateral Sclerosis.
    Collins MA; An J; Hood BL; Conrads TP; Bowser RP
    J Proteome Res; 2015 Nov; 14(11):4486-501. PubMed ID: 26401960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrospinal fluid erythropoietin (EPO) in amyotrophic lateral sclerosis.
    Brettschneider J; Widl K; Schattauer D; Ludolph AC; Tumani H
    Neurosci Lett; 2007 Apr; 416(3):257-60. PubMed ID: 17368721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurement of cystatin C levels in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
    Ren Y; Zhu W; Cui F; Yang F; Chen Z; Ling L; Huang X
    Int J Clin Exp Pathol; 2015; 8(5):5419-26. PubMed ID: 26191245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amino acids acting as transmitters in amyotrophic lateral sclerosis (ALS).
    Niebroj-Dobosz I; Janik P
    Acta Neurol Scand; 1999 Jul; 100(1):6-11. PubMed ID: 10416506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal fluid levels of free 3-nitrotyrosine are not elevated in the majority of patients with amyotrophic lateral sclerosis or Alzheimer's disease.
    Ryberg H; Söderling AS; Davidsson P; Blennow K; Caidahl K; Persson LI
    Neurochem Int; 2004 Jul; 45(1):57-62. PubMed ID: 15082222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.